These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

766 related articles for article (PubMed ID: 38136211)

  • 1. Metabolic Syndrome: A Narrative Review from the Oxidative Stress to the Management of Related Diseases.
    Martemucci G; Fracchiolla G; Muraglia M; Tardugno R; Dibenedetto RS; D'Alessandro AG
    Antioxidants (Basel); 2023 Dec; 12(12):. PubMed ID: 38136211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Strategies for Metabolic Syndrome: How Nutrition, Dietary Polyphenols, Physical Activity, and Lifestyle Modifications Address Diabesity, Cardiovascular Diseases, and Neurodegenerative Conditions.
    Martemucci G; Khalil M; Di Luca A; Abdallah H; D'Alessandro AG
    Metabolites; 2024 Jun; 14(6):. PubMed ID: 38921462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer.
    Tsuei J; Chau T; Mills D; Wan YJ
    Exp Biol Med (Maywood); 2014 Nov; 239(11):1489-504. PubMed ID: 24951470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting endothelial metaflammation to counteract diabesity cardiovascular risk: Current and perspective therapeutic options.
    Potenza MA; Nacci C; De Salvia MA; Sgarra L; Collino M; Montagnani M
    Pharmacol Res; 2017 Jun; 120():226-241. PubMed ID: 28408314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysbiosis versus diabesity: Pathological signaling and promising therapeutic strategies.
    Sharma AK; Sharma A; Lal S; Kumar A; Yadav NK; Tabassum F; Sayeed Akhtar M; Tarique Imam M; Saeed Almalki Z; Mukherjee M
    Drug Discov Today; 2023 May; 28(5):103558. PubMed ID: 36948384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors.
    Silveira Rossi JL; Barbalho SM; Reverete de Araujo R; Bechara MD; Sloan KP; Sloan LA
    Diabetes Metab Res Rev; 2022 Mar; 38(3):e3502. PubMed ID: 34614543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabesity and mood disorders: Multiple links through the microbiota-gut-brain axis.
    Farzi A; Hassan AM; Zenz G; Holzer P
    Mol Aspects Med; 2019 Apr; 66():80-93. PubMed ID: 30513310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 Diabetes Mellitus Associated with Obesity (Diabesity). The Central Role of Gut Microbiota and Its Translational Applications.
    Ortega MA; Fraile-Martínez O; Naya I; García-Honduvilla N; Álvarez-Mon M; Buján J; Asúnsolo Á; de la Torre B
    Nutrients; 2020 Sep; 12(9):. PubMed ID: 32917030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox-inflammatory synergy in the metabolic syndrome.
    Bryan S; Baregzay B; Spicer D; Singal PK; Khaper N
    Can J Physiol Pharmacol; 2013 Jan; 91(1):22-30. PubMed ID: 23368637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis.
    Kuraji R; Shiba T; Dong TS; Numabe Y; Kapila YL
    World J Gastroenterol; 2023 Feb; 29(6):967-996. PubMed ID: 36844143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Mechanisms of Obesity-Linked Cardiac Dysfunction: An Up-Date on Current Knowledge.
    Gutiérrez-Cuevas J; Sandoval-Rodriguez A; Meza-Rios A; Monroy-Ramírez HC; Galicia-Moreno M; García-Bañuelos J; Santos A; Armendariz-Borunda J
    Cells; 2021 Mar; 10(3):. PubMed ID: 33809061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic Insights Into Gut Microbiome Dysbiosis-Mediated Neuroimmune Dysregulation and Protein Misfolding and Clearance in the Pathogenesis of Chronic Neurodegenerative Disorders.
    Padhi P; Worth C; Zenitsky G; Jin H; Sambamurti K; Anantharam V; Kanthasamy A; Kanthasamy AG
    Front Neurosci; 2022; 16():836605. PubMed ID: 35281490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease.
    Holvoet P
    Verh K Acad Geneeskd Belg; 2008; 70(3):193-219. PubMed ID: 18669160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of the gut in the metabolic syndrome: an overview.
    Fändriks L
    J Intern Med; 2017 Apr; 281(4):319-336. PubMed ID: 27991713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the Mucosa-Associated Microbiome and Transcriptome across Gut Segments Are Associated with Obesity in a Metabolic Syndrome Porcine Model.
    Xu SS; Wang N; Huang L; Zhang XL; Feng ST; Liu SS; Wang Y; Liu ZG; Wang BY; Wu TW; Mu YL; Hou SH; Li K
    Microbiol Spectr; 2022 Aug; 10(4):e0071722. PubMed ID: 35862956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota and short chain fatty acids partially mediate the beneficial effects of inulin on metabolic disorders in obese ob/ob mice.
    Guo J; Zhang M; Wang H; Li N; Lu Z; Li L; Hui S; Xu H
    J Food Biochem; 2022 May; 46(5):e14063. PubMed ID: 35128673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the gut microbiota in type 2 diabetes and related diseases.
    Yang G; Wei J; Liu P; Zhang Q; Tian Y; Hou G; Meng L; Xin Y; Jiang X
    Metabolism; 2021 Apr; 117():154712. PubMed ID: 33497712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between Gut Microbiota, Gut Hyperpermeability and Obesity.
    Gasmi A; Mujawdiya PK; Pivina L; Doşa A; Semenova Y; Benahmed AG; Bjørklund G
    Curr Med Chem; 2021; 28(4):827-839. PubMed ID: 32693755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. THE INTESTINAL MICROBIOME IN PATIENTS UNDERGOING BARIATRIC SURGERY: A SYSTEMATIC REVIEW.
    Gentile JKA; Oliveira KD; Pereira JG; Tanaka DY; Guidini GN; Cadona MZ; Siriani-Ribeiro DW; Perondini MT
    Arq Bras Cir Dig; 2022; 35():e1707. PubMed ID: 36542005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.